Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4243180

Cc1cc(-n2cc(C(=O)NC(=N)N)c3ccccc32)c2ccccc2n1.O=C(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIK3R2 O00459 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.39
NCF1 P14598 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 1/20 0.37
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
RAB9A P51151 2/20 0.36
KDM4E B2RXH2 1/20 0.36
RORC P51449 1/20 0.36
NPC1 O15118 1/20 0.35
F2 P00734 1/20 0.35
F10 P00742 1/20 0.35
PRSS1 P07477 1/20 0.35
PRSS2 P07478 1/20 0.35
PRSS3 P35030 1/20 0.35
USP2 O75604 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4240199 0.94 L3MBTL1 (0.43) PIK3R2L3MBTL1NCF1SMN1; SMN2LMNA
SCHEMBL4244687 0.87 GAA (0.38) PIK3R2L3MBTL1NCF1SMN1; SMN2LMNA
SCHEMBL4239462 0.87 GAA (0.44) L3MBTL1KDM4ERORC
SCHEMBL4243183 0.86 PIK3R2 (0.37) PIK3R2L3MBTL1NCF1SMN1; SMN2LMNA
SCHEMBL4245433 0.85 ADRB2 (0.43) SMN1; SMN2LMNAADRB2MEN1KMT2A
Hydrochloric Acid SCHEMBL4240234 0.85 ADRB2 (0.43) SMN1; SMN2LMNAADRB2MEN1KMT2A
Trifluoroacetic Acid SCHEMBL4242769 0.84 MALT1 (0.34) L3MBTL1LMNAKDM4ERORC
Trifluoroacetic Acid SCHEMBL6082140 0.84 L3MBTL1 (0.39) PIK3R2L3MBTL1NCF1SMN1; SMN2LMNA
SCHEMBL4243769 0.82 CD38 (0.40) MEN1KMT2ARORC
SCHEMBL4060598 0.82 SMN1; SMN2 (0.42) PIK3R2L3MBTL1NCF1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7638521-B2 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2009-12-29 US disclosed
US-20040214820-A1 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040214820-A1 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them IDO1, IDO2, HTR3C PIK3R2 2322/4885L3MBTL1 4827/4885NCF1 3098/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.